Un tratament experimental ar putea îmbunătăți structura osoasă și reduce acumularea de grăsime după menopauză

An experimental treatment shows promise in enhancing bone structure and reducing fat accumulation in postmenopausal mice. Initially developed for cancer therapy, the substance CADD522 stimulates bone tissue formation without hindering normal bone resorption. The study indicates that this treatment could offer a new approach to osteoporosis management by promoting bone formation while maintaining bone integrity. Additionally, it leads to metabolic changes, including reduced body weight and fat tissue, without affecting food intake. The findings suggest potential implications for both bone health and lipid metabolism post-menopause, although further research is needed to understand the underlying mechanisms and safety for human use.